CVO-Europe Societe Nouvelle, SAS

CVO-Europe Societe Nouvelle, SAS specializes in consulting services for the Life Sciences sector, focusing on validation, quality assurance, and regulatory compliance to support clients in enhancing operational efficiency. Founded in 1995 and headquartered in Lyon, France, CVO-Europe provides consulting services tailored to the Life Sciences industry. The company was acquired by EFOR Consultants – SAS in January 2021, with financial terms undisclosed. There is no mention of significant changes in business strategy or operations since its inception.

CVO-Europe specializes in tailored consulting services within the Life Sciences sector, focusing on validation, quality assurance, regulatory compliance, risk management, and auditing. Their core offerings include clinical audits, regulatory affairs audits, and mock inspections, which enhance operational efficiency and ensure adherence to industry standards. The company supports pharmaceutical companies, biotechnology firms, and medical device manufacturers primarily across European markets such as Belgium, France, and Switzerland, providing expert training and comprehensive assessments to address compliance challenges. In the most recent financial year, 2019, CVO-Europe recorded a revenue of USD 31.

95 mn and an EBITDA amounting to USD 519,945. The company generates revenue through a structured model involving consulting services, training programs, and audit assessments, typically engaging in B2B transactions with clients in the Life Sciences sector. CVO-Europe intends to leverage its recent acquisition to expand its market presence and enhance its service offerings. Although specific new products are not mentioned, the company aims to grow its geographical footprint and strengthen its consulting capabilities.

The recent acquisition will likely facilitate these initiatives, aligning with the strategic goals set forth by EFOR Consultants, the majority stakeholder.